These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22613528)
21. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM; Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731 [TBL] [Abstract][Full Text] [Related]
22. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS. Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514 [TBL] [Abstract][Full Text] [Related]
23. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143 [TBL] [Abstract][Full Text] [Related]
24. Five-year clinical results of coronary angioplasty with drug-eluting stents. National initiative in strategic innovation, iNOS. Baptista J; Teles RC; da Silva PC; Pereira H; Marques L; Santos R; Carvalho H; Martins D; Farto e Abreu P; Araújo J; ; Teles RC; Almeida M; Raposo L; da Silva PC; Gabriel HM; Pereira H; Vinhas H; Leitão-Marques A; Costa M; Baptista J; Santos R; Seixo F; Farto e Abreu P; Carvalho H; Luz A; Martins D; Araújo J; Silva B Rev Port Cardiol; 2010 Feb; 29(2):243-51. PubMed ID: 20545251 [TBL] [Abstract][Full Text] [Related]
26. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
27. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of effects between China made sirolimus-eluting stents and bare stents for treating patients with acute myocardial infarction]. Jin HG; Liu ZJ; Yang W; Wang WQ; Shi J; Wang DY; Wang ZH; Yu HM; Lai Y; Shen J; Fang P Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):697-700. PubMed ID: 17963624 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal analysis of the effect of smoking cessation on cardiovascular risk factors in a community sample: the Busselton Study. Bartholomew HC; Knuiman MW J Cardiovasc Risk; 1998 Aug; 5(4):263-71. PubMed ID: 9919475 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694 [TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study). Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967 [TBL] [Abstract][Full Text] [Related]
32. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome? Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents. Chen SL; Xu B; Mintz G; Ye F; Zhang JJ; Kan J; Sun XW; Zhang AP; Chen JG; Qian J; Kwan TW Chin Med J (Engl); 2010 Apr; 123(7):794-9. PubMed ID: 20497666 [TBL] [Abstract][Full Text] [Related]
34. Influence of insulin resistance on long-term outcomes in patients. Zhao LP; Lü AK; Shen WF; Liu HF; Ma XY; Fan XM; Zhang Q Chin Med J (Engl); 2010 Mar; 123(6):651-7. PubMed ID: 20368081 [TBL] [Abstract][Full Text] [Related]
36. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention. Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250 [TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045 [TBL] [Abstract][Full Text] [Related]